AmplifiDx, based in Newark, CA, is a leading provider of next-generation molecular point-of-care platforms. Their flagship product, the DX 1000 System, stands out for its combination of visual appeal, ease of use, low cost, and high performance. With fast turnaround and high sensitivity, the DX 1000 delivers clear and actionable COVID-19 results directly to a connected mobile device in as little as 30 minutes, enabling infected individuals to quickly isolate and prevent further spread.
AmplifiDx's innovative technology bridges the gap between laboratory PCR tests and point-of-care devices, offering a reliable solution for rapid and accurate diagnostics. By providing fast and accessible results, AmplifiDx plays a crucial role in combating the spread of infectious diseases, empowering individuals and healthcare professionals with the tools they need to make informed decisions and take immediate action.
Generated from the website